Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Varaine

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Sante (Montrouge, France)|February 28, 2002
[Detection of meningococcal meningitis epidemics in Africa: a new recommendation]R Lewis, N Nathan, A Communier, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|June 20, 2018
Is 6 months of bedaquiline enough? Results from the compassionate use of bedaquiline in Armenia and GeorgiaC Hewison, M Bastard, N Khachatryan, et al.
Antimicrobial Agents and Chemotherapy|March 16, 2021
Thin-Layer-Agar-Based Direct Phenotypic Drug Susceptibility Testing on Sputum in Eswatini Rapidly Detects Mycobacterium tuberculosis Growth and Rifampicin Resistance Otherwise Missed by WHO-Endorsed Diagnostic TestsE Ardizzoni, E Ariza, D Mulengwa, et al.
Antimicrobial Agents and Chemotherapy|April 9, 2025
Phenotypic and genotypic resistance to bedaquiline in patients with multi-drug-resistant tuberculosis-experiences from ArmeniaE Ardizzoni, W Mulders, M De Diego Fuertes, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|February 28, 2023
Concordance of three approaches for operationalizing outcome definitions for multidrug-resistant TBC Zeng, C D Mitnick, C Hewison, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|October 31, 2020
Setting up pharmacovigilance based on available endTB Project data for bedaquilineN Lachenal, C Hewison, C Mitnick, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|May 26, 2023
Outcomes of WHO-conforming, longer, all-oral multidrug-resistant TB regimens and analysis implicationsM L Rich, U Khan, C Zeng, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|October 31, 2020
Introducing new and repurposed TB drugs: the endTB experienceK J Seung, U Khan, F Varaine, et al.
Trials|September 26, 2021
Evaluating newly approved drugs for multidrug-resistant tuberculosis (endTB): study protocol for an adaptive, multi-country randomized controlled trialL Guglielmetti, E Ardizzoni, M Atger, et al.
The European Respiratory Journal|August 11, 2011
WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 updateD Falzon, E Jaramillo, H J Schünemann, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Sante (Montrouge, France)|February 28, 2002
[Detection of meningococcal meningitis epidemics in Africa: a new recommendation]R Lewis, N Nathan, A Communier, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|June 20, 2018
Is 6 months of bedaquiline enough? Results from the compassionate use of bedaquiline in Armenia and GeorgiaC Hewison, M Bastard, N Khachatryan, et al.
Antimicrobial Agents and Chemotherapy|March 16, 2021
Thin-Layer-Agar-Based Direct Phenotypic Drug Susceptibility Testing on Sputum in Eswatini Rapidly Detects Mycobacterium tuberculosis Growth and Rifampicin Resistance Otherwise Missed by WHO-Endorsed Diagnostic TestsE Ardizzoni, E Ariza, D Mulengwa, et al.
Antimicrobial Agents and Chemotherapy|April 9, 2025
Phenotypic and genotypic resistance to bedaquiline in patients with multi-drug-resistant tuberculosis-experiences from ArmeniaE Ardizzoni, W Mulders, M De Diego Fuertes, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|February 28, 2023
Concordance of three approaches for operationalizing outcome definitions for multidrug-resistant TBC Zeng, C D Mitnick, C Hewison, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|October 31, 2020
Setting up pharmacovigilance based on available endTB Project data for bedaquilineN Lachenal, C Hewison, C Mitnick, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|May 26, 2023
Outcomes of WHO-conforming, longer, all-oral multidrug-resistant TB regimens and analysis implicationsM L Rich, U Khan, C Zeng, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|October 31, 2020
Introducing new and repurposed TB drugs: the endTB experienceK J Seung, U Khan, F Varaine, et al.
Trials|September 26, 2021
Evaluating newly approved drugs for multidrug-resistant tuberculosis (endTB): study protocol for an adaptive, multi-country randomized controlled trialL Guglielmetti, E Ardizzoni, M Atger, et al.
The European Respiratory Journal|August 11, 2011
WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 updateD Falzon, E Jaramillo, H J Schünemann, et al.
Pageof 5